Skip to main content

CORRECTION article

Front. Neurol., 27 March 2023
Sec. Applied Neuroimaging
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1178013

Corrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series

This article is a correction to:

  1. Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series

    1. Read original article
\nStefano BerloffaStefano Berloffa1Andrea Salvati&#x;Andrea Salvati2†Gloria Pantalone&#x;Gloria Pantalone2†Ludovica Falcioni&#x;Ludovica Falcioni3†Micaela M. Rizzi&#x;Micaela M. Rizzi3†Francesca Naldini&#x;Francesca Naldini3†Gabriele MasiGabriele Masi1Antonella Gagliano, Antonella Gagliano3,4*
  • 1IRCCS Stella Maris, Scientific Institute of Child Neurology and Psychiatry, Pisa, Italy
  • 2Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
  • 3Child and Adolescent Neuropsychiatry Unit, Department of Biomedical Science, University of Cagliari & “A. Cao” Pediatric Hospital, Brotzu Hospital Trust, Cagliari, Italy
  • 4Neurology Unit, Department of Neurology of Health Science, Magna Graecia University of Catanzaro, Catanzaro, Italy

A corrigendum on
Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series

by Berloffa, S., Salvati, A., Pantalone, G., Falcioni, L., Rizzi, M. M., Naldini, F., Masi, G., and Gagliano, A. (2023). Front. Neurol. 14:1085948. doi: 10.3389/fneur.2023.1085948

In the published article, the Funding statement was mistakenly omitted. The correct Funding statement appears below.

This work has been partially supported by a grant from the IRCCS Fondazione Stella Maris (Ricerca Corrente, and the “5 × 1000” voluntary contributions, Italian Ministry of Health).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, TIC, pediatric acute-onset neuropsychiatric syndrome (PANS), steroid, neuropsychiatric disorder

Citation: Berloffa S, Salvati A, Pantalone G, Falcioni L, Rizzi MM, Naldini F, Masi G and Gagliano A (2023) Corrigendum: Steroid treatment response to post SARS-CoV-2 PANS symptoms: Case series. Front. Neurol. 14:1178013. doi: 10.3389/fneur.2023.1178013

Received: 02 March 2023; Accepted: 13 March 2023;
Published: 27 March 2023.

Edited and reviewed by: Paola Iannetti, Faculty of Medicine and Dentistry, Sapienza University of Rome, Italy

Copyright © 2023 Berloffa, Salvati, Pantalone, Falcioni, Rizzi, Naldini, Masi and Gagliano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Antonella Gagliano, antonellagagliano.npi@gmail.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.